Roberts Zachary — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Roberts Zachary has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $104K.

Profile

Zachary Roberts is identified as the Executive Vice President of Research and Development at Allogene Therapeutics, Inc. in SEC insider filings dated 2026-01-23 (CIK 0001851044). The filing reports no insider purchases or sales by Mr. Roberts in that period. Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic CAR-T therapies for cancer and autoimmune diseases.

Board memberships

• Allogene Therapeutics, Inc.

Awards & honors

• Leading R&D strategy at Allogene Therapeutics
• Overseeing development of allogeneic CAR-T programs

Recent Transactions

Companies — Last 90 Days

• Allogene Therapeutics, Inc. (ALLO) — 1 filings, last 2026-07-06

Frequently Asked Questions

Who is Roberts Zachary?

Zachary Roberts is identified as the Executive Vice President of Research and Development at Allogene Therapeutics, Inc. in SEC insider filings dated 2026-01-23 (CIK 0001851044). The filing reports no insider purchases or sales by Mr. Roberts in that period. Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic CAR-T therapies for cancer and auto…

How many SEC Form 4 filings has Roberts Zachary submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Roberts Zachary been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($104K) across all tracked filings.

Where can I see all of Roberts Zachary's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week